Miami Cancer Institute to Present Latest Research at 2025 Annual Meeting of the American Society of Clinical Oncology
MIAMI, FL & CHICAGO, IL – May 5, 2025 – Miami Cancer Institute, part of Baptist Health South Florida, today announced its presentations at this year’s annual meeting of the American Society of Clinical Oncology (ASCO), May 30 – June 3, at McCormick Place in Chicago, Illinois. Miami Cancer Institute’s presentations this year include advances in the treatment of glioblastoma, brain metastases, breast cancer, as well as testicular and bladder cancer.
“Our presentations at the ASCO annual meeting this year cover a wide spectrum of disease states and research areas,” said Manmeet Singh Ahluwalia, M.D., MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of Miami Cancer Institute, and Fernandez Family Foundation Endowed Chair in Cancer Research. “The research presented covers a study into liquid biopsy in glioblastoma patients, a new approach using transcranial ultrasound to treat brain metastases, and results from a trial studying a combination immunotherapy in patient with rare tumor brain cancer metastases, among many others.”
In addition, Zouina Sarfraz, MBBS, postdoctoral fellow at Miami Cancer Institute, received a prestigious ASCO 2025 Conquer Cancer Merit Award, which is awarded for high-quality abstracts submitted to an ASCO Meeting by trainees and students and encourages their attendance at the meeting.
Miami Cancer Institute’s presentations at ASCO 2025 include:
Poster Presentations
Saturday, May 31, 2025
A multicenter, pivotal trial of microbubble-enhanced transcranial focused ultrasound (MB-FUS) for plasma-based liquid biopsy in patients with glioblastoma (LIBERATE).
Presenter: Manmeet Singh Ahluwalia, MD, MBA, FASCO
Time: 09:00 a.m. – 12:00 p.m. CT
Location: Hall A
Poster #: 137a
A multicenter, randomized, controlled, pivotal trial of microbubble-enhanced transcranial focused ultrasound for patients with NSCLC brain metastases (LIMITLESS).
Presenter: Manmeet Singh Ahluwalia, MD, MBA, FASCO
Time: 09:00 a.m. – 12:00 p.m. CT
Location: Hall A
Poster #: 134b
A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION).
Presenter: Rupesh Kotecha, MD
Time: 09:00 a.m. – 12:00 p.m. CT
Location: Hall A
Poster #: 68
Diagnostic accuracy of machine learning models in glioma classification: A meta-analysis.
Presenter: Zouina Sarfraz, MBBS
Time: 09:00 a.m. – 12:00 p.m. CT
Location: Hall A
Poster #: 125
Frequency and spectrum of BRCA pathogenic/likely pathogenic variants in the Hispanic population of south Florida: A retrospective analysis.
Presenter: Srika Amin, MMSc, CGC
Time: 01:30 p.m. – 04:30 p.m. CT
Location: Hall A
Poster #: 304
Real-world evidence from FLEX: Utility of MammaPrint in guiding treatment planning for patients aged 70 and older with early-stage breast cancer.
Presenter: Reshma L. Mahtani, DO
Time: 01:30 p.m. – 04:30 p.m. CT
Location: Hall A
Poster #: 514
Recent trends in cancer distribution and survival outcomes among adolescent and young adult patients: A national data analysis.
Presenter: Fatma Nihan Akkoc Mustafayev, MD
Time: 01:30 p.m. – 04:30 p.m. CT
Location: Hall A
Poster #: 286
Monday, June 2, 2025
Prognostic impact of brain metastases on survival rates in patients with metastatic testicular cancer: A comprehensive registry-based analysis.
Presenter: Rohan Garje, MD
Time: 09:00 a.m. – 12:00 p.m. CT
Location: Hall A
Poster #: 222
Risk of radiation necrosis with concurrent antibody-drug conjugates and radiotherapy in HER2-positive breast cancer with brain metastases: A meta-analysis.
Presenter: Zouina Sarfraz, MBBS
Time: 09:00 a.m. – 12:00 p.m. CT
Location: Hall A
Poster #: 18
Survival outcomes of whole pelvic vs. bladder-only radiation in muscle-invasive bladder cancer: A nationwide large-scale study.
Presenter: Mohammad Arfat Ganiyani, MBBS
Time: 09:00 a.m. – 12:00 p.m. CT
Location: Hall A
Poster #: 400
The impact of racial and socioeconomic disparities on radiation therapy delays in breast cancer patients: A National Cancer Database analysis.
Presenter: Mehmet Murat Zerey, MD
Time: 09:00 a.m. – 12:00 p.m. CT
Location: Hall A
Poster #: 133
Barriers to palliative care access in patients with brain metastases: A comprehensive national study.
Presenter: Zouina Sarfraz, MBBS
Time: 01:30 p.m. – 04:30 p.m. CT
Location: Hall A
Poster #: 115
Efficacy and toxicity of nivolumab and ipilimumab in rare cancer brain metastases: A multi-center basket trial analysis.
Presenter: Manmeet Singh Ahluwalia, MD, MBA, FASCO
Time: 01:30 p.m. – 04:30 p.m. CT
Location: Hall A
Poster #: 266
For updates from the 2025 ASCO Annual Meeting, look for #ASCO25 on social media and follow Miami Cancer Institute on X (Twitter) at @MiamiCancerInst.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit https://cancer.baptisthealth.net/miami-cancer-institute.
Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.
###
